CGEN FY 2021 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$215M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+200.0% YoY

Gross Profit

$5M88.7% margin

Operating Income

-$35M-584.6% margin

Net Income

-$34M-570.0% margin

EPS (Diluted)

$-0.41

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$132M

Total Liabilities

$25M

Stockholders' Equity

$107M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$2M	+200.0%
Gross Profit	$5M	$2M	+174.2%
Operating Income	-$35M	-$31M	-11.4%
Net Income	-$34M	-$30M	-15.2%